In the first three months of the year, there were 323 active medication shortages, surpassing the previous high of 320 shortages in 2014. It also amounts to the most shortages since a pharmacists' trade group started keeping track in 2001.
Medicare's actuaries expect the drug Leqembi to cost the traditional Medicare program around $550 million in 2024 and the entire Medicare program $3.5 billion in 2025.
Three advocacy groups are pushing the Biden administration to use federal laws to license patents on a cancer treatment to outside manufacturers in order to produce lower-cost versions.
The reports of an Ozempic baby boom are anecdotal, and it's not known how widespread the phenomenon is. Experts say significant weight loss can affect fertility.
The FDA on Thursday approved the novel antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for treating serious bacterial infections in adults and children.